quetiapine has been researched along with Depression, Endogenous in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Quetiapine is an atypical antipsychotic drug that is also US FDA approved for treating bipolar depression, albeit by an unknown mechanism." | 1.35 | N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity. ( Caron, MG; Jensen, NH; Rodriguiz, RM; Roth, BL; Rothman, RB; Wetsel, WC, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jensen, NH | 1 |
| Rodriguiz, RM | 1 |
| Caron, MG | 1 |
| Wetsel, WC | 1 |
| Rothman, RB | 1 |
| Roth, BL | 1 |
1 other study available for quetiapine and Depression, Endogenous
| Article | Year |
|---|---|
N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antipsychotic Agents; Brain Chemistry; | 2008 |